Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index; 3 of the 10 sources its claims cite were checked for support.

Editorial: Constructing the vascular or cardiac tissue and organoids: the combination of biomedicine and engineering

Open access
Sun, Dayu, Katare, Rajesh, Sethu, Palaniappan, Cheng, Panke, Fan, Yonghong · 2024 · Frontiers in Cardiovascular Medicine

Abstract

EDITORIAL article Front. Cardiovasc. Med., 16 February 2024Sec. Cardiovascular Biologics and Regenerative Medicine Volume 11 - 2024 | https://doi.org/10.3389/fcvm.2024.1371074

Overview

CoChat Summary

## TL;DR

This editorial introduces a Research Topic on bioengineered vascular and cardiac tissues/organoids as promising strategies for cardiovascular disease, framed as a collaboration between biomedicine and engineering. It briefly summarizes three reviews and one original research article, highlighting scaffold-based small-caliber vascular grafts and cardiac microtissues as key directions.

## Key findings

  • Traditional vascular grafts are described as limited by supply and complications from mechanical stress, inflammatory responses, and inconsistent remodeling; bioengineered vascular tissue may be remodeled by the host and “even grow with young patients.”
  • The review by Leal et al. covers small-caliber vascular graft development, manufacturing techniques, materials, animal studies, and clinical trials, and the editorial states that a cell-free scaffold-based small-diameter TEVG made from biocompatible polymers “would meet the significant clinical demand.”
  • Reyat et al. developed vascularized, chamber-specific cardiac microtissues using hiPSC-derived atrial or ventricular cardiomyocytes plus vascular sprouts from human blood vessel organoids; the resulting microtissues had gene expression, architecture, and electrophysiology comparable to in vivo-derived cardiac tissues.
  • Pro-fibrotic stimulation in Reyat et al.’s microtissues recapitulated cardiac fibrosis, and the phenotype was reversible with a receptor inhibitor, suggesting utility for disease modelling and pharmacological screening.

## Methods

  • Editorial overview of a Research Topic that includes three review articles and one original research article on bioengineered vascular tissue and bioengineered cardiac tissue.
  • Summarizes published approaches rather than reporting a new study design; the text describes topics including scaffold-based grafts, ventricle biofabrication strategies, and bone marrow vasculature models.
  • For the original work summarized, the paper describes combining hiPSC-derived atrial or ventricular cardiomyocytes with vascular sprouts from human blood vessel organoids to create chamber-specific cardiac microtissues.

## Limitations

  • The editorial does not report original experimental limitations or quantitative outcomes for most of the summarized papers; only brief qualitative descriptions are given.
  • Evident from the text: it is a high-level editorial summary, so many details about sample sizes, protocols, and statistical analyses are not stated in the paper.
  • The editorial’s conclusions about promise for clinical treatment are aspirational and not supported here by direct outcome data from the editorial itself.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fcvm.2024.1371074

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

3 Valid · 0 Not valid · 7 Not checked · 1 Own results and interpretations

4 more claims

Create a free account to see all 11 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 2

Create a free account to see these claims.

Citations

Cites

Show all 13 references

Metadata

Authors
Sun, D., Katare, R., Sethu, P., Cheng, P., & Fan, Y.
Affiliations
  • Army Medical University (CN)
  • University of Otago (NZ)
  • University of Alabama at Birmingham (US)
  • University of Electronic Science and Technology of China (CN)
  • Chengdu Military General Hospital (CN)
Corresponding author
Sun, Dayu
Venue
Frontiers in Cardiovascular Medicine
Published
2024-02-16
Volume
11
Pages
1371074-1371074
ISSN
2297-055X (ISSN-L)
OpenAlex
W4391881117
Cited by
0
References
13
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Cardiovascular Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
vascular tissue engineering, cardiac tissue engineering, organoids, cardiovascular regenerative medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Editorial: Constructing the vascular or cardiac tissue and organoids: the combination of biomedicine and engineering. https://app.cochat.ai/papers/10.3389/fcvm.2024.1371074
The paper
Sun, D., Katare, R., Sethu, P., Cheng, P., & Fan, Y. (2024). Editorial: Constructing the vascular or cardiac tissue and organoids: the combination of biomedicine and engineering. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2024.1371074

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.